Coronary heart disease results from the interplay of dozens of risk factors, not a single cause. The traditional list most people know, including high cholesterol, smoking, high blood pressure, diabetes, and physical inactivity, accounts for a large share of heart attacks, but research over the past two decades has expanded the map considerably. Factors like chronic inflammation, air pollution, gut bacteria, and even age-related mutations in bone marrow cells now figure into the picture, and some of them influence risk independently of anything on the classic checklist.
Cholesterol, Plaque, and Why Context Matters
Elevated LDL cholesterol has been linked to coronary heart disease for decades, and the evidence remains strong. But the relationship is more textured than a simple “high LDL equals high risk.” A large study of over 23,000 patients in western Denmark found that LDL cholesterol was associated with future cardiovascular events only in people who already had some degree of coronary artery calcium, a marker of existing plaque buildup. Among the roughly half of patients with no detectable calcium, even very high LDL levels above 193 mg/dL did not meaningfully predict events. In contrast, among those with plaque already present, very high LDL roughly doubled the hazard compared with lower levels.1Circulation. Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis
This does not mean LDL is harmless if you have a clean calcium scan. LDL drives the process of plaque formation over years, and a zero calcium score today does not guarantee one tomorrow. But the finding helps explain why some people with high LDL never have a heart attack while others with moderate levels do: what matters is not just the amount of cholesterol in your blood but whether it has already started damaging your arteries.
Smoking and the Blood Vessel Assault
Smoking attacks the cardiovascular system on multiple fronts simultaneously. It raises blood pressure, promotes oxidative stress, triggers inflammation in artery walls, disrupts the inner lining of blood vessels, encourages blood clots, and worsens cholesterol profiles.2Pflügers Archiv – European Journal of Physiology. Tobacco smoking and vascular biology and function: evidence from human studies The combination is particularly dangerous because these effects reinforce one another. Damaged endothelium becomes stickier, platelets and immune cells pile on, and the resulting environment is ripe for plaque to grow and eventually rupture.3Arteriosclerosis, Thrombosis, and Vascular Biology. Smoking and Cardiovascular Disease
One aspect that surprises some people: smoking also interferes with the effectiveness of blood-thinning medications. A study of patients who had undergone stent placement showed that platelet reactivity increased after smoking, though the clinical significance of that particular effect appeared modest.4PubMed Central. A Systematic Review of the Effects of Smoking on the Cardiovascular System and General Health The bigger issue is the sheer breadth of the damage. Smoking is not just one risk factor; it is a bundle of risk factors stuffed into one habit.
Insulin Resistance and the Metabolic Cascade
When your cells stop responding normally to insulin, the consequences extend well beyond blood sugar. Insulin resistance sets off a cascade of metabolic problems: chronic high blood sugar drives oxidative stress and inflammation, lipid metabolism goes awry, and the inner lining of blood vessels starts to malfunction.5PubMed Central. Association between insulin resistance and the development of cardiovascular disease The lipid pattern is distinctive and recognizable: triglycerides climb, protective HDL drops, and LDL particles become smaller and denser, a combination that is especially good at infiltrating artery walls and building plaque.
All of this happens before anyone gets formally diagnosed with type 2 diabetes. The altered insulin signaling promotes obesity, low-grade inflammation, high blood pressure, and endothelial dysfunction, each of which is itself a recognized contributor to atherosclerosis.6PubMed Central. Insulin resistance and cardiovascular disease In other words, the metabolic dysfunction that precedes diabetes is already doing cardiovascular damage long before a fasting glucose test looks alarming. This is part of why abdominal obesity shows up so consistently as a predictor of heart disease: it is a visible proxy for the invisible metabolic storm underneath.
Inflammation as an Independent Driver
For years, inflammation was considered a consequence of atherosclerosis rather than a cause. That view has shifted. Chronic, low-grade systemic inflammation now looks like an independent force pushing the disease forward, and measuring it adds real predictive power beyond traditional risk factors.
The most accessible marker is high-sensitivity C-reactive protein, or hsCRP. A major study in the general population found that people with hsCRP levels above 3 mg/L had roughly a third higher risk of major cardiovascular events, about 60 percent higher risk of cardiovascular death, and about 50 percent higher risk of death from any cause, compared with those whose levels were below 1 mg/L.7European Heart Journal. C-reactive protein and cardiovascular risk in the general population The predictive power of hsCRP ranked above several conventional risk factors and improved existing risk calculators by reclassifying about 14 percent of patients into more accurate risk categories.
Separate data from patients presenting with chest pain confirmed the pattern: those with the highest hsCRP levels experienced all-cause death rates roughly four times higher than those with the lowest levels over a median follow-up of about five years. Elevated hsCRP predicted death and major cardiovascular events independently of age, sex, and standard risk factors.8European Heart Journal. Hs-CRP is a strong predictor of adverse cardiovascular events in patients with chest pain The implication is that even after you account for cholesterol, blood pressure, and smoking, residual inflammation adds a measurable layer of risk that standard panels miss.
Diet, Ultra-Processed Foods, and the Mediterranean Pattern
Diet influences coronary risk through nearly every pathway discussed so far: lipids, blood sugar, inflammation, blood pressure. A large prospective study from Italy, the Moli-sani Study, found that people who closely followed a traditional Mediterranean diet while also keeping ultra-processed food intake low had about a quarter lower risk of dying from any cause and about a fifth lower risk of cardiovascular death compared with those who had a poor diet and high ultra-processed food consumption.9PubMed. Combination of a traditional Mediterranean Diet with ultra-processed food consumption in relation to all-cause and cause-specific mortality The two dietary factors, Mediterranean adherence and ultra-processed food avoidance, appeared to work together, amplifying each other’s effects on ischemic heart disease mortality.
What makes this more concerning is that ultra-processed foods seem to carry risk even when the overall diet looks reasonably healthy. In a Greek population study, each additional weekly serving of ultra-processed food was associated with higher cardiovascular disease incidence, and the harmful effect persisted, only slightly weakened, even among people with moderate-to-high adherence to the Mediterranean pattern. Among those with low Mediterranean diet adherence, the per-serving risk was substantially stronger.10European Heart Journal. Ultra-processed foods and ten-year cardiovascular disease incidence in a Mediterranean population The takeaway: a generally good diet helps, but ultra-processed items appear to carry their own independent penalty, not fully cancelled out by eating plenty of vegetables and olive oil alongside them.
Physical Activity and the Dose-Response Curve
Exercise is included in the American Heart Association’s “Life’s Essential 8” for cardiovascular health, and the data behind that inclusion are strong across all life stages.11Circulation Research. Physical Activity Over the Lifecourse and Cardiovascular Disease A meta-analysis that pooled data from multiple cohorts quantified the relationship: meeting the standard guideline of 150 minutes per week of moderate-intensity activity was associated with about a 14 percent lower risk of coronary heart disease compared with being completely sedentary. Doubling that to 300 minutes per week bought an additional benefit, bringing the risk reduction to roughly 20 percent.12Circulation. Dose Response Between Physical Activity and Risk of Coronary Heart Disease
Two things stand out. First, even amounts of activity below the recommended minimum were linked to significantly lower risk, meaning that something is genuinely better than nothing. Second, the curve flattens at higher levels. Going from zero to 150 minutes buys you the largest increment of protection; going from 300 to 600 adds relatively little. For most people, the practical message is that a brisk walk most days of the week gets you a large share of the heart-health benefit available from exercise.
Lipoprotein(a), the Inherited Wild Card
Most lipid risk factors respond to diet, exercise, or medication. Lipoprotein(a), often written as Lp(a), is different. Its level in your blood is almost entirely determined by your genes, and standard statin therapy barely moves it.13Journal of the American Heart Association. Genetics and Pathophysiological Mechanisms of Lipoprotein(a)‐Associated Cardiovascular Risk That makes it an important gap in the traditional risk factor framework: a person can have textbook-perfect cholesterol panels and still carry high Lp(a) that quietly promotes plaque formation.
Genetic studies have pinpointed variants in the LPA gene that drive high Lp(a) levels and simultaneously increase coronary disease risk, providing strong evidence that the relationship is causal, not merely a statistical coincidence. One common variant carries an odds ratio for coronary disease of about 1.7, and another independent variant carries an odds ratio of roughly 1.9.14PubMed. Genetic variants associated with Lp(a) lipoprotein level and coronary disease Given how common these variants are, Lp(a) may be the single strongest genetic risk factor for cardiovascular disease identified so far.15PubMed Central. Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases Several pharmaceutical companies are now testing drugs designed specifically to lower Lp(a), but as of now, there is no approved targeted treatment. Knowing your level at least lets you and your doctor manage other risk factors more aggressively if needed.
Psychosocial Stress and Social Isolation
Stress is commonly cited as a heart disease risk factor but often dismissed as vague. The data, while harder to pin down than a cholesterol number, consistently point to real effects. A case-control study found elevated cardiovascular risk among people with a history of work stress, social isolation, marital stress, childhood abuse, and major trauma, with odds ratios ranging from roughly 2.3 to 3.2 depending on the stressor type.16PubMed Central. Psychological Stress as a Risk Factor for Cardiovascular Disease: A Case-Control Study – Section: Results Pooled analyses have estimated that socially isolated populations face about a 50 percent higher risk of cardiovascular disease and that people working in high-pressure environments face roughly 40 percent higher risk.
The mechanisms are both direct and indirect. Chronic stress elevates cortisol, raises blood pressure, promotes inflammation, and disrupts sleep, all of which feed into the pathways already discussed. Indirectly, stressed and isolated people tend to smoke more, eat worse, exercise less, and skip medical care. The risk is real even if it is hard to reduce to a single biomarker.
Air Pollution, an Invisible Contributor
Fine particulate matter, the tiny particles known as PM2.5, acts on the cardiovascular system through oxidative stress, activation of inflammatory immune pathways, and stimulation of the autonomic nervous system, leading to endothelial dysfunction and accelerated atherosclerosis.17International Journal of Cardiology Cardiovascular Risk and Prevention. PM2.5 and cardiovascular diseases: State-of-the-Art review These are the same downstream mechanisms that smoking, insulin resistance, and chronic stress exploit, which helps explain why air pollution amplifies risk even in people who do everything else right.
Long-term exposure studies have connected elevated particulate and nitrogen dioxide levels to higher blood pressure, worse cholesterol profiles, higher fasting blood sugar, and elevated inflammatory markers among older adults.18Occupational and Environmental Medicine. Long-term air pollution exposure and risk factors for cardiovascular diseases among the elderly in Taiwan In other words, air pollution does not just irritate the lungs. It quietly pushes multiple traditional risk factors in the wrong direction, making them worse than they would otherwise be. People living near major roads or in cities with poor air quality carry a chronic cardiovascular burden that does not show up on a standard risk questionnaire.
Socioeconomic Status and Structural Disadvantage
Low income, limited education, and lack of health insurance are each independently associated with higher coronary heart disease rates.19American Journal of Preventive Cardiology. Socioeconomic status, cardiovascular risk profile, and premature coronary heart disease People with low socioeconomic status experience roughly double the rates of early heart attacks and coronary death compared with their higher-income peers, and traditional risk factors like smoking and obesity explain only part of the gap. Simulations using the Cardiovascular Disease Policy Model estimated that about 60 percent of the excess heart attacks and coronary deaths in lower-income groups was attributable to the independent effects of socioeconomic status itself and related upstream factors, beyond what conventional risk factors would predict.20JAMA Cardiology. Association of Low Socioeconomic Status With Premature Coronary Heart Disease in US Adults
Strong inverse socioeconomic gradients in cardiovascular risk have been observed across racial and ethnic groups in the United States, with physical inactivity, smoking, and abdominal obesity partially explaining the relationship.21PubMed Central. Socioeconomic and ethnic disparities in cardiovascular risk in the United States, 2001-2006 The mechanisms are layered: chronic stress from financial insecurity, reduced access to healthy food and safe places to exercise, barriers to medical care, and environmental exposures like pollution all cluster together in disadvantaged communities. Addressing coronary heart disease at a population level means grappling with these structural determinants, not just handing out statins.
Polygenic Risk and Genetic Screening
Family history has always been recognized as a coronary risk factor, but modern genomics is making the genetic contribution more quantifiable. Genome-wide studies have identified hundreds of common genetic variants, each contributing a small amount of risk, that can now be aggregated into a single polygenic risk score.22PubMed Central. Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease The American Heart Association has recognized these scores as a potential tool for cardiovascular risk prediction.23Circulation. Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association
Unlike Lp(a), which reflects a single powerful genetic factor, polygenic risk scores capture the aggregate effect of many small-effect variants. The promise is that this information reflects lifelong exposure to genetically mediated risk, which could be useful for identifying people who need earlier or more intensive prevention. The limitation is that most existing scores were developed in European-ancestry populations and may not perform equally well in other groups. Clinical adoption is still in early stages, and a polygenic risk score does not yet change treatment guidelines for most people. But it is an area where the science is moving fast.
Coronary Artery Calcium Scanning
One of the more practical advances in risk assessment is the coronary artery calcium (CAC) scan, a low-dose CT that measures the amount of calcified plaque in coronary arteries. A meta-analysis found that even low amounts of calcium (a score between 1 and 100) roughly doubled the risk of coronary events compared with a zero score, and high scores above 400 were associated with relative risks between about 4 and 17 times higher.24JAMA Internal Medicine. Using the Coronary Artery Calcium Score to Predict Coronary Heart Disease Events: A Systematic Review and Meta-analysis Adding the CAC score to standard risk factor models significantly improved risk classification, reclassifying about a quarter of people who went on to have events into higher risk categories and moving a meaningful fraction of event-free people into lower risk categories.25JAMA. Coronary Artery Calcium Score and Risk Classification for Coronary Heart Disease Prediction
The CAC score is most useful for people whose risk sits in an uncertain middle zone, where the decision to start preventive medication is genuinely unclear. A zero score in such a person provides strong reassurance; a high score can tip the balance toward more aggressive treatment. It is less useful at the extremes: someone who already has known heart disease does not need a calcium scan, and someone in their 20s with no risk factors would almost certainly score zero.
Menopause and Sex-Specific Shifts
Women generally develop coronary heart disease about a decade later than men, and much of that protection appears tied to estrogen. Estrogen promotes blood vessel dilation through nitric oxide release, has calcium-blocking effects on artery walls, and inhibits the growth of smooth muscle cells that contribute to plaque formation.26Pathophysiology of Haemostasis and Thrombosis. Menopause and cardiovascular risk When menopause arrives and estrogen production drops sharply, those protections fade. Lipid profiles shift, glucose metabolism worsens, and coronary risk accelerates. The discovery of estrogen receptors on coronary arteries in both pre- and post-menopausal women has helped clarify why these vessels are particularly sensitive to hormonal changes. This does not mean hormone replacement therapy is straightforwardly protective; clinical trial results have been more complicated than the biological rationale would suggest. But the menopausal transition is a clear inflection point for women’s coronary risk.
Clonal Hematopoiesis, a Recently Discovered Risk Factor
One of the newest entries on the coronary risk factor list comes from an unexpected place: the bone marrow. As people age, some blood-forming stem cells acquire mutations that give them a growth advantage, producing expanding clones of slightly altered white blood cells. This phenomenon, called clonal hematopoiesis of indeterminate potential, or CHIP, becomes increasingly common after middle age. It carries no cancer symptoms and was only recently linked to the heart at all.
The connection is striking. In nested case-control analyses from two prospective cohorts, carriers of CHIP had roughly double the risk of coronary heart disease compared with non-carriers. In separate cohorts of early-onset heart attack patients, CHIP carriers had about four times the risk.27PubMed Central. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease These mutant immune cells appear to be more inflammatory than normal ones, driving plaque growth through overproduction of inflammatory signaling molecules.28Journal of the American Heart Association. Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist’s Point of View The doubled risk persists even after accounting for traditional cardiovascular risk factors like cholesterol, blood pressure, and smoking.29PubMed Central. Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer
There is no clinical test or treatment specifically targeting CHIP-related heart disease yet, but the finding has reshaped how researchers think about coronary risk in aging. It suggests that some of the “unexplained” heart disease in older adults with clean risk factor profiles may trace back to acquired mutations in their own immune cells.
Gut Bacteria and the TMAO Pathway
Your gut bacteria process certain dietary nutrients, particularly choline, carnitine, and lecithin found in red meat, eggs, and some fish, into a compound called trimethylamine. The liver then converts that into trimethylamine N-oxide, or TMAO, which circulates in the blood. Elevated TMAO has been linked to atherosclerosis and blood clot formation.30Arteriosclerosis, Thrombosis, and Vascular Biology. Gut Microbiota–Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes
The mechanisms are plausible and well-mapped: TMAO reduces nitric oxide production in blood vessel walls, triggers inflammatory signaling, interferes with the body’s process for clearing excess cholesterol, promotes foam cell formation inside arteries, and increases platelet reactivity, making clots more likely.31PubMed Central. TMAO and Cardiovascular Disease: Exploring Its Potential as a Biomarker The end result touches several of the same pathways that traditional risk factors exploit: more LDL getting into artery walls, more inflammation once it is there, and a greater tendency to form dangerous clots. Whether TMAO will prove to be a useful clinical target or merely an interesting biomarker is still an open question, but it has opened an entirely new front in understanding how diet and the microbiome interact to shape coronary risk.
Chronic Infections and Coronary Risk
The idea that infections play a role in heart disease has been debated for decades, and the picture remains nuanced. A study published in Circulation found that elevated antibody levels to herpes simplex virus type 1 (HSV-1) and Chlamydia pneumoniae were both independently associated with coronary heart disease. The relationship was dramatically amplified by inflammation: among people with both high antibody levels to HSV-1 and elevated CRP, the odds ratio for coronary disease was roughly 25 compared with people who had low levels of both. For Chlamydia pneumoniae, the same combination yielded an odds ratio of about 5.32Circulation. Infections, Inflammation, and the Risk of Coronary Heart Disease
These findings do not mean that catching a cold gives you a heart attack. The infections in question are chronic, persistent ones that may smolder for years, contributing a low-level inflammatory burden that interacts with other cardiovascular risk pathways. Antibiotic trials targeting Chlamydia pneumoniae failed to reduce heart attack rates, so simply treating the infection does not appear to solve the problem. The more important lesson is that chronic systemic inflammation, whatever its source, makes every other risk factor worse.
Atherosclerosis in Ancient Humans
One of the more humbling findings in cardiovascular research comes from CT scans of mummies. The Horus study and its extensions examined preserved human remains spanning thousands of years and multiple continents. Among 52 Egyptian mummies, nearly half had definite or probable atherosclerosis, spanning virtually every era of ancient Egypt represented in the study, a time period of over 2,000 years.33PubMed. Atherosclerosis in ancient Egyptian mummies: the Horus study A larger follow-up study of 237 mummified adults from multiple ancient cultures, including pre-agricultural hunter-gatherers, found atherosclerotic calcifications in about 38 percent of the sample, distributed similarly between men and women and between Egyptian and non-Egyptian populations.34European Heart Journal. Atherosclerosis in ancient mummified humans: the global HORUS study
The conclusion is provocative: atherosclerosis is not purely a disease of modern life. It appears to be an inherent human vulnerability, present even in populations without processed food, sedentary jobs, or cigarettes.35The Lancet. Horus study collaboration: Atherosclerosis across 4000 years of human history Modern risk factors, then, may act more as accelerants than as root causes, amplifying and worsening a process that humans have always been prone to. That framing does not diminish the importance of controlling those risk factors. It does, however, suggest that the goal of eliminating coronary heart disease entirely may run up against something fundamental in human biology.